Saturday 17 October 2026
Export ASIX’s income statement to Excel — free account
AdvanSix
ASIX Basic Materials Chemicals
AdvanSix’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, roughly unchanged from fiscal 2024. In the quarter to June 2026, revenue grew 2.75%, EPS fell 89.7%, free cash flow fell 49.2% and total debt rose 14.6%, each against the same quarter a year earlier. Dividend growth for five consecutive years.
16.25
0.25
−1.52%
Follow ASIX
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
9.94 | 9.40 | 62.56 | 0.00 |
P/S ratio |
0.35 | 0.31 | 0.43 | 0.34 | |
P/FCF ratio |
4,831.90 | 72.51 | 0.00 | 0.00 | |
P/Operating CF |
19.63 | 7.30 | (42.94) | 53.56 | |
P/B ratio |
0.64 | 0.57 | 0.83 | 0.67 | |
Price to Tangible BV |
0.72 | 0.65 | 0.94 | 0.77 | |
EV/Sales |
0.51 | 0.45 | 0.60 | 0.53 | |
EV/EBITDA |
5.91 | 4.82 | 9.92 | 11.65 | |
EV/Operating CF |
6.20 | 5.51 | 9.65 | 9.67 | |
EV/FCF |
7,083.56 | 105.56 | (41.73) | (31.93) | |
Quick Ratio |
0.69 | 0.50 | 0.67 | 0.65 | |
Current Ratio |
1.36 | 1.13 | 1.23 | 1.28 | |
Net Debt/EBITDA |
12.27 | 9.87 | 106.73 | 8.92 | |
Debt/Assets |
14.81% | 12.60% | 15.78% | 16.44% | |
Debt/Equity |
0.31 | 0.26 | 0.34 | 0.35 | |
Asset Turnover |
0.93 | 0.92 | 0.93 | 0.94 | |
Operating CF/Net income |
(10.08) | (22.83) | 0.99 | 3.09 | |
Capex/Depreciation |
(1.29) | (1.32) | (1.70) | (0.99) | |
Interest Coverage |
(0.88) | (0.48) | (7.70) | 3.47 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
7.32% | 7.92% | 5.57% | 5.23% | |
Intangible Assets out of Total Assets |
0.06 | 0.06 | 0.06 | 0.06 | |
Share Based Compensation of Revenue |
0.44% | 0.25% | 0.51% | 0.44% | |
Graham Net Nets |
(0.80) | (0.97) | (0.70) | (0.84) | |
Graham Number |
36.51 | 35.42 | 16.09 | 0.00 | |
Earnings Yield |
10.06% | 10.64% | 1.60% | (3.32%) | |
Free Cash Flow Yield |
0.02% | 1.38% | (3.38%) | (4.79%) | |
Revenue per Share |
13.91 | 13.38 | 14.98 | 15.58 | |
Operating CF per Share |
0.99 | 2.37 | (0.57) | 0.37 | |
Capex per Share |
(0.98) | (1.03) | (1.33) | (0.77) | |
Free Cash Flow per Share |
0.00 | 1.34 | (1.90) | (0.39) | |
Cash per Share |
0.88 | 0.73 | 0.65 | 0.27 | |
Shareholders Equity per Share |
30.39 | 30.30 | 29.51 | 29.47 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
30.39 | 30.30 | 29.51 | 29.47 | |
Free Cash Flow |
0.07 | 36.13 | (51.27) | (10.68) | |
Working Capital |
120.67 | 50.66 | 83.56 | 93.12 | |
Capital Expenditures |
(26.52) | (27.60) | (35.94) | (20.71) | |
Net Current Asset Value |
(415.12) | (450.32) | (460.47) | (451.24) | |
EV/EBIT |
15.03 | 11.26 | 81.29 | 0.00 | |
Capex to Sales |
0.07 | 0.08 | 0.09 | 0.05 | |
Price to Operating Income |
10.26 | 7.73 | 57.69 | 0.00 | |
| Other line items | |||||
Average Receivables |
178.84 | 160.94 | 204.55 | 191.44 | |
Average Payables |
221.66 | 256.39 | 261.62 | 237.60 | |
Average Inventory |
211.28 | 224.44 | 212.11 | 207.95 | |
Average Assets |
1,599.29 | 1,650.53 | 1,668.36 | 1,659.71 | |
Average Common Equity |
792.32 | 794.93 | 795.33 | 810.32 |
Columns are period end dates